USPTO serial 77646548
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Botanical extracts for use in the manufacture of nutraceuticals; extracts for use in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts for use in the manufacture of pharmaceuticals; chemical extracts extracted from medicinal plants for use in the manufacture of nutraceuticals and pharmaceuticals; chemical extracts namely, chemical agents made from botanical extracts or association of chemical extracts for use in the manufacture of pharmaceutical or nutraceutical products; botanical extracts used in the manufacture of preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanicals and botanical blends, herbs and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, algal extracts and algal extract blends, all for use in the manufacture of nutritional supplements and vitamins; herbal extracts and blends for use in manufacturing functional foods or beverages; herbal extracts and blends for use in manufacturing medicinal foods or beverages; botanical extracts and blends for use in manufacturing functional foods or beverages; botanical extracts and blends for use in manufacturing medicinal foods or beverages; herbal preparations and extracts for use as ingredients in manufacturing in the food, nutrition, nutraceutical and/or pharmaceutical industries; medicinal herbal extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts used as component ingredients of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection used to treat skin ailments, for infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory, cancer and related conditions; active principles extracted from medicinal plants for use in the manufacture of pharmaceutical or nutraceutical products | ACTIVE | — |
| 003 | Herbal products, namely, aromatherapy packs filled with herbs for use in aromatherapy; pre-moistened non-medicated personal hygiene wipes, namely, herpes relief wipes; herbal and botanical extracts for cosmetic use; algal extracts or algal extract blends for cosmetic use; essential oils; fragrances; fragrances for personal use; food flavorings prepared from essential oils | ACTIVE | — |
| 005 | Nutritional supplements; herbal products, namely, nutritional additives for medical purposes for use in foods and dietary supplements, herbal products, namely, medicated skin and lip balms; medicated herbal and botanical extracts for cosmetic use; drinks, namely, meal replacement drinks, dietary supplement drinks, medicinal drinks, and fish oil for use as a dietary supplement or in a nutraceutical; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; nutritional additives for medical or nonmedical purposes for use in manufacturing foods and dietary supplements for human consumption; herbal products for medicinal purposes, namely, herbal extracts and syrups; medicinal herb extracts; medicinal herb extracts for medical purposes; plant extracts for medical, pharmaceutical, nutraceutical and nutritional purposes; medicinal extracts used in preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; medicinal extracts used in pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; yeast extracts for medical, pharmaceutical or nutraceutical purposes; herbal products, namely, herbal powders for nutritional purposes; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, herbal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; pharmaceuticals and nutraceuticals, namely, vitamins and food supplements; botanical extracts for nutritional use; botanical extracts used as ingredients in pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, inhalers, tincture, suppositories and ampule for injection; botanical extracts for medical, nutraceutical and pharmaceutical purposes; designer extracts, namely, herbal extracts for medical and pharmaceutical purposes; botanical extracts for nutritional supplements, nutraceuticals and pharmaceuticals; botanical extracts sold as an integral ingredient of nutritional supplements, nutraceuticals and pharmaceuticals; herbal preparations and extracts for use as ingredients in the food, nutrition, nutraceutical and/or pharmaceutical industry; nutritional dietary supplements; oral preparations containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; nutraceuticals, namely, vitamins and food supplements; food for medically restricted diets; supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; food supplements, namely, anti-oxidants; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends, all sold as components of nutritional supplements and vitamins; food supplements, namely, lipid concentrates for use as a dietary food supplement or for pharmaceutical or medicinal purposes; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; algal products for medicinal purposes, namely, algal extracts or algal extract blends for use as nutritional and dietary supplements; algal products, namely, algal powders sold as an integral ingredient of nutritional supplement drink mix for nutritional purposes; algal products, namely, algal powders for nutritional purposes; algal extracts or algal extract blends for medical or pharmaceutical purposes; plant extracts for medical and pharmaceutical purposes; herbal extracts for medical and pharmaceutical purposes; designer extracts, namely, plant, herbal and botanical extracts for medical and pharmaceutical purposes; nutritional additives for medical and nonmedical purposes for use in manufacturing foods and dietary supplements for human consumption | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 24, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 20, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 22, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 16, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 15, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 11, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 11, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 11, 2009 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Jun 10, 2009 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jun 10, 2009 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Jun 10, 2009 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| May 15, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 15, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 12, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 15, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 15, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2009 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Jan 13, 2009 | NWAP | NEW APPLICATION ENTERED | — |